Back to Results

Check Cap Ltd (MBAI)

Check Cap Ltd. is a clinical-stage medical diagnostics company focused on capsule-based screening technologies. The company was incorporated in 2004 and is based in Isfiya, Israel. Its common stock is listed on NASDAQ under the ticker MBAI. As an early-stage healthcare company, Check Cap’s business is centered on developing diagnostic products for screening applications.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding
NASDAQ-MBAI
Not available
Not available
Not available
Weak
0.0%
November 23, 2026
187.0x
40.7x
97.573 M
94.59 M
0.0%
49.7%
Valuation • Fair Value

Check Cap Ltd (NASDAQ-MBAI) Fair Value by Valuation Model

Review the available estimates for Check Cap Ltd (NASDAQ-MBAI), including Ben Graham Formula Value.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Ben Graham Formula Value

$0.37

Classic Ben Graham valuation formula reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the available valuation reference for Check Cap Ltd (NASDAQ-MBAI) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Check Cap Ltd (NASDAQ-MBAI)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

2.335 M

Current operating scale indicator.

Revenue Forecast

0 K

Forward revenue estimate.

EBITDA

567.397 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Check Cap Ltd (NASDAQ-MBAI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Check Cap Ltd (NASDAQ-MBAI)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

3

Weak quality score that deserves closer review.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Check Cap Ltd (NASDAQ-MBAI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Check Cap Ltd (NASDAQ-MBAI)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 23, 2026

Days to Earnings

62

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Check Cap Ltd (NASDAQ-MBAI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Check Cap Ltd (NASDAQ-MBAI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Check Cap Ltd (NASDAQ-MBAI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Check Cap Ltd (NASDAQ-MBAI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Check Cap Ltd (NASDAQ-MBAI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Check Cap Ltd (NASDAQ-MBAI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Check Cap Ltd (NASDAQ-MBAI) Stock FAQ

Data-supported answers about Check Cap Ltd (NASDAQ-MBAI), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Weak
Current financial-health read

A reliable fair value estimate is not currently available for Check Cap Ltd (NASDAQ-MBAI). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Check Cap Ltd (NASDAQ-MBAI) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Check Cap Ltd (NASDAQ-MBAI) is November 23, 2026.

The latest available data indicates no current dividend yield for Check Cap Ltd (NASDAQ-MBAI).

The current P/E ratio listed for Check Cap Ltd (NASDAQ-MBAI) is 187.0x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Check Cap Ltd is 97.573 M.

The current enterprise value listed for Check Cap Ltd is 94.59 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Check Cap Ltd is NASDAQ-MBAI, and the stock is listed on NASDAQ.

Check Cap Ltd (NASDAQ-MBAI) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Check Cap Ltd is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Check Cap Ltd is 49.7%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 179.4 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 142 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 116.1 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 105.5 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 65.099 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 51.173 B
BDX NYSE Becton Dickinson and Co Fair Value Undervalued Market Cap 49.847 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 44.185 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 41.084 B
DXCM NASDAQ DexCom Inc Fair Value Undervalued Market Cap 33.785 B
RMD NYSE ResMed Inc Fair Value Undervalued Market Cap 31.756 B
ALC NYSE Alcon AG Fair Value Undervalued Market Cap 31.674 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Undervalued Market Cap 29.933 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Undervalued Market Cap 24.452 B
STE NYSE STERIS plc Fair Value Undervalued Market Cap 20.357 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Undervalued Market Cap 17.926 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 15.107 B
PEN NYSE Penumbra Inc Fair Value Fair Market Cap 12.581 B
BAX NYSE Baxter International Inc Fair Value Fair Market Cap 12.242 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 11.566 B